1
Return

GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study

delete2026-07-11
delete0
delete
OA
AI
R
Rebecca A Nelson
Y
Ying-Chuen Lai
S
Sung H Kil
H
Hayley S Lee
J
Joanne Mortimer
P
Ping H Wang *
DOI：10.1093/oncolo/oyag268delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Diabetes and obesity are associated with worse prognosis in women with breast cancer. However, the impact of glucagon-like peptide-1 receptor agonists (GLP-1RA) on survival following breast cancer diagnosis remains unclear.

Journal

T
the oncologist
IF:
0
Papers:
188
Citations:
0

Organization

N
national taiwan university hospital
Scholars:
9.4K
Papers: 8.2K
Citations: 6
A
arthur riggs diabetes & metabolism research institute and beckman research institute and city of hope
Scholars:
3
Papers: 1
Citations: 0
B
Beckman Research Institute
Scholars:
113
Papers: 33
Citations: 5.1K
City Of Hope National Medical Center cover
City Of Hope National Medical Center
Scholars:
106
Papers: 37
Citations: 5.8K
Cited Papers

Cited Papers

Citing Papers

Citing Papers